Transthyretin, Amyloidosis

Transthyretin Amyloidosis Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Players - Attralus, Alnylam Pharmaceuticals, Ionis Pharmaceuticals, AstraZeneca, Alexion Pharmaceuticals, Novo Nordisk

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

DelveInsight Business Research, LLP United States of America United Kingdom


+91-9650213330
www.delveinsight.com  

Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg

 

Cision View original content:https://www.prnewswire.co.uk/news-releases/transthyretin-amyloidosis-market-is-predicted-to-exhibit-remarkable-growth-by-2032-predicts-delveinsight--key-players---attralus-alnylam-pharmaceuticals-ionis-pharmaceuticals-astrazeneca-alexion-pharmaceuticals-novo-nordisk-302042875.html

en | boerse | 67973700 |